4 recruiting, 3 not yet recruiting, 1 active not recruiting, 1 unknown. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Recruiting 4, Not yet recruiting 3, Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Etoposide Injection: new trials by email Literature Review of Etoposide Injection trials Research Report on Etoposide Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma Gemcitabine (GEM), Etoposide Injection, Dexamethasone - Natural Killer/T-cell Lymphoma | Phase 2 | Not yet recruiting | Fudan University | 620 | 2026-09-01 | 2026-08-17 |
| SKB500 Combinations in Patients With Small Cell Lung Cancer SKB500 Powder for Injection, KL-A167 Injection, Carboplatin Injection - Small Cell Lung Cancer | Phase 2 | Recruiting | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 80 | 2026-01-30 | 2026-05-08 |
| A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors SHR-7787 Injection, SHR-1316 Injection, SHR-4849 Injection - Malignant Solid Tumors | Phase 2 | Recruiting | Shanghai Hengrui Pharmaceutical Co., Ltd. | 400 | 2025-12-23 | 2026-01-12 |
| A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer Apatinib, Adebrelimab, Etoposide Injection - Small Cell Lung Cancer Extensive Stage | Phase 2 | Not yet recruiting | Fujian Cancer Hospital | 34 | 2025-01-25 | 2025-01-22 |
| PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC Tislelizumab, Carboplatin injection, Cisplatin injection - Limited-stage Small-cell Lung Cancer | Phase 2 | Not yet recruiting | Beijing Chest Hospital, Capital Medical University | 60 | 2024-04-16 | 2024-04-19 |
| Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML Homoharringtonine, Cytarabine, Etoposide - AML, Childhood, Acute Myeloid Leukemia | Phase 2 | Recruiting | Children's Hospital of Soochow University | 500 | 2024-01-01 | 2024-08-22 |
| A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma LBL-024 for Injection, Etoposide Injection, Carboplatin Injection - Advanced Neuroendocrine Carcinoma | Phase 1 / Phase 2 | Recruiting | Nanjing Leads Biolabs Co.,Ltd | 178 | 2023-12-08 | 2026-03-12 |
| Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC serplulimab, Cisplatin, Carboplatin - Extensive-stage Small-cell Lung Cancer | Phase 2 | Active not recruiting | Sichuan University | 61 | 2023-03-07 | 2026-04-29 |
| First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC Etoposide Injection, Carboplatin Injection, Cisplatin injection - Small Cell Lung Carcinoma | Phase 2 | Unknown | Taizhou Hospital | 20 | 2020-05-01 | 2020-04-28 |
Small Cell Lung Carcinoma (5) · Leukemia, Myeloid, Acute (1) · Lymphoma, Extranodal NK-T-Cell (1)
Beijing Chest Hospital, Capital Medical University (1) · Children's Hospital of Soochow University (1) · Fudan University (1) · Fujian Cancer Hospital (1) · Nanjing Leads Biolabs Co.,Ltd (1) · Shanghai Hengrui Pharmaceutical Co., Ltd. (1) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1) · Sichuan University (1) · Taizhou Hospital (1)
China (8)
Chuanxu Liu, MD (1) · Dongqing Lv, MD (1) · Rong Tao, MD (1) · Shaoyan Hu, MD, PhD (1) · Xuejun Ma, MD (1) · Yilong Wu (1) · You Lu, MD (1)